Cathérine Hollerbach

Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line

Aline Fiebig‐Comyn, Weijia Zhu, Cathérine Hollerbach et al. · BMC Cancer · 2006 · 106 citations · Full text

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

Frank Kullmann, S. Hollerbach, Matthias Dollinger et al. · British Journal of Cancer · 2009 · 90 citations · Full text

Identification of the Endoplasmic Reticulum Targeting Signal in Vesicle-associated Membrane Proteins

Peter K. Kim, Cathérine Hollerbach, William S. Trimble et al. · Journal of Biological Chemistry · 1999 · 52 citations · Full text

Impact of Obesity on Neuropathic Late Complications in NIDDM

Rainer H. Straub, Markus Thum, Cathérine Hollerbach et al. · Diabetes Care · 1994 · 43 citations